One Nucleus is partnering with Taylor Wessing to hold a panel to discuss current trends in cell & gene therapy partnering and deal-making, in particular how these deals differ from those for more traditional modalities.
In this interactive event the panel will share insights on how the unique characteristics of C> products and technologies drive different approaches to deal-marking. Topics for the panel will include:
16.00: Welcome from One Nucleus
16.05: Panel discussion with
Chair: Adrian Toutoungi, Partner at Taylor Wessing
Attend this talk to learn how to put together a successful partnering deal for cell and gene therapy partnering deal and understand what the innovators, big pharma and investors are looking for.
Although there will be opportunity to pose questions on the day, you are invited to submit your questions in advance to Aline, email@example.com
Free to attend and open to all